summari updat libr tracker report includ
preliminari data publish iqvia inc formerli im health
incorpor week end see figur
rais price target base
updat iqvia libr data june preliminari iqvia
weekli prescript data releas week end
preliminari data provid breakdown libr sensor
reader prescript separ howev reader prescript
run new libr prescript
nrx recent week estim new reader
prescript week end vs week
end week-over-week suspect volum
week end impact memori day holiday
histor prescript data
iqvia recent restat rx data earlier year iqvia
variou
drugs/product track includ libr implement new
report methodolog go forward basi
updat libr tracker align restat iqvia number
import consider import note
iqvia captur new prescript new patient thu use
iqvia data estim new patient could overst
number patient truli new therapi believ new
reader prescript current best avail analog new
libr patient given patient need purchas one
reader remain rel earli launch reader
nrx volum remain robust worth note could see
impact come weeks/month fda approv
abt smartphon app approv given smartphon
app elimin patient need readerw suspect reader nrx
could trend lower convers understand launch
abt sensor approv result double-
count sensor nrx data despit caveat iqvia
data continu help baromet adopt view
said would caution investor read much
weekli fluctuat nrx trend place undu relianc
data
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
ep exclud amort intang ep continu
oper ep includ stj amo alr deal
compani data secur llc estim reuter
data week end preliminari base estim
note nrx sensor data may double-count due launch sensor
iqvia inc secur llc estim
data week end preliminari base estim
note reader nrx may impact fda approv smartphon app
iqvia inc secur llc estim
prescriptionsweek prescriptionsweek endednrx abbott laboratori
data week end preliminari base estim
iqvia inc secur llc estim
data week end preliminari base estim
note reader trx may impact fda approv smartphon app
iqvia inc secur llc estim
analysi independ arriv well fargo secur llc basi data
inform iqvia inc respons relianc recipi either data
analys thereof
prescriptionsweek prescriptionsweek endedtrx medic technolog
price target
price target base ep estim risk target includ
slower growth key busi market delay stj alr integr slower margin
expect continu deliv double-digit underli ep growth mid-singl digit underli
sale growth oper leverag
abbott laboratori diversifi global medic product compani four key busi segment
nutrit diagnost establish pharmaceut epd medic devic compani report
total revenu compani acquir stj januari nearli doubl
